TIGIT and melanoma: The T cell immunoreceptor with Ig and ITIM domains (TIGIT)/CD55 axis contributes to immune suppression by suppressing T cell recruitment and activation, thereby reducing the immune system’s ability to target melanoma cells effectively [59].